techwiki
ghentllms.txt

Chris Cardon

Chris Cardon is founder and CEO of Ziphius Vaccines, a Ghent-based biopharmaceutical startup developing self-amplifying RNA (saRNA) vaccines, which raised EUR 29.3 million in a Series A round.

Cardon co-founded Ziphius Vaccines in 2019 alongside Kristof Vercruysse, Mathieu Ghadanfar, and Tom Almey. The company's saRNA platform allows cells to replicate vaccine instructions and amplify the immune response, enabling significantly lower required doses compared to conventional mRNA vaccines. Ziphius has established manufacturing collaborations with UZ Ghent and Charles River Laboratories, and research partnerships with the University of Antwerp on RNA delivery optimization.

Career

Roles
  • ZiphiusFounder Ziphius VaccinesJul 2019 – Present
  • ZiphiusChief Executive OfficerJun 2019 – Present
  • Animalcare group PlcMember Board Of Directors Animalcare group PlcJul 2017 – Jul 2021
  • ECUPHARFounder Ecuphar, renamed Animalcare GroupJan 2001 – Jul 2019
  • mooss pharmaFounder Mooss Pharma1996 – 2001
Education

From public career histories · 7 entries